Ilyas JA, O’Mahony CA, Vierling JM (2011) Liver transplantation in autoimmune liver diseases. Best Pract Res Clin Gastroenterol 25:765–782. https://doi.org/10.1016/j.bpg.2011.09.008
Manns MP, Czaja AJ, Gorham JD, Krawitt EL, Mieli-Vergani G, Vergani D, Vierling JM (2010) Diagnosis and management of autoimmune hepatitis. Hepatology 51:2193–2213. https://doi.org/10.1002/hep.23584
Article CAS PubMed Google Scholar
Gomes NBN, Torres US, Ferraz MLCG, D’Ippolito G (2021) Autoimmune hepatitis in practice, from diagnosis to complications: what is the role of imaging? A clinicoradiological review. Clin Imaging 74:31–40. https://doi.org/10.1016/j.clinimag.2020.12.032
Thomaides-Brears HB, Alkhouri N, Allende D, Harisinghani M, Noureddin M, Reau NS, French M, Pantoja C, Mouchti S, Cryer DRH (2022) Incidence of complications from percutaneous biopsy in chronic liver disease: a systematic review and meta-analysis. Dig Dis Sci 67:3366–3394. https://doi.org/10.1007/s10620-021-07089-w
Bedossa P, Carrat F (2009) Liver biopsy: the best, not the gold standard. J Hepatol 50:1–3. https://doi.org/10.1016/j.jhep.2008.10.014
Heneghan MA, Shumbayawonda E, Dennis A, Ahmed RZ, Rahim MN, Ney M, Smith L, Kelly M, Banerjee R, Culver EL (2022) Quantitative magnetic resonance imaging to aid clinical decision making in autoimmune hepatitis. EClinicalMedicine 46:101325. https://doi.org/10.1016/j.eclinm.2022.101325
Article PubMed PubMed Central Google Scholar
Bajre M, Moawad M, Shumbayawonda E, Carolan JE, Hart J, Culver E, Heneghan M (2022) LiverMultiScan as an alternative to liver biopsy to monitor autoimmune hepatitis in the National Health Service in England: an economic evaluation. BMJ Open. https://doi.org/10.1136/bmjopen-2021-058999
Article PubMed PubMed Central Google Scholar
Wang Q, Kesen S, Liljeroth M, Nilsson H, Zhao Y, Sparrelid E, Brismar TB (2022) Quantitative evaluation of liver function with gadoxetic acid enhanced MRI: Comparison among signal intensity-, T1-relaxometry-, and dynamic-hepatocyte-specific-contrast-enhanced MRI- derived parameters. Scand J Gastroenterol 57:705–712. https://doi.org/10.1080/00365521.2022.2032321
Mesropyan N, Kupczyk P, Dold L, Weismüller TJ, Sprinkart AM, Mädler B, Pieper CC, Kuetting D, Strassburg CP, Attenberger U, Luetkens JA (2021) Non-invasive assessment of liver fibrosis in autoimmune hepatitis: diagnostic value of liver magnetic resonance parametric mapping including extracellular volume fraction. Abdom Radiol 46:2458–2466. https://doi.org/10.1007/s00261-020-02822-x
Arndtz K, Shumbayawonda E, Hodson J, Eddowes PJ, Dennis A, Thomaides-Brears H, Mouchti S, Kelly MD, Banerjee R, Neubauer S, Hirschfield GM (2021) Multiparametric magnetic resonance imaging autoimmune hepatitis, and prediction of disease activity. Hepatol Commun 5:1009–1020. https://doi.org/10.1002/hep4.1687
Article CAS PubMed PubMed Central Google Scholar
Janowski K, Shumbayawonda E, Cheng L, Langford C, Dennis A, Kelly M, Pronicki M, Grajkowska W, Wozniak M, Pawliszak P, Chełstowska S, Jurkiewicz E, Banerjee R, Socha P (2021) Quantitative multiparametric MRI as a non-invasive stratification tool in children and adolescents with autoimmune liver disease. Sci Rep. https://doi.org/10.1038/s41598-021-94754-9
Article PubMed PubMed Central Google Scholar
Janowski K, Shumbayawonda E, Dennis A, Kelly M, Bachtiar V, Debrota D, Langford C, Thomaides-Brears H, Pronicki M, Grajkowska W, Wozniak M, Pawliszak P, Chełstowska S, Jurkiewicz E, Banerjee R, Socha P (2021) Multiparametric MRI as a noninvasive monitoring tool for children with autoimmune hepatitis. J Pediatr Gastroenterol Nutr 72:108–114. https://doi.org/10.1097/MPG.0000000000002930
Article CAS PubMed Google Scholar
Pavlides M, Banerjee R, Sellwood J, Kelly CJ, Robson MD, Booth JC, Collier J, Neubauer S, Barnes E (2016) Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease. J Hepatol 64:308–315. https://doi.org/10.1016/j.jhep.2015.10.009
Article PubMed PubMed Central Google Scholar
Hoffman DH, Ayoola A, Nickel D, Han F, Chandarana H, Shanbhogue KP (2020) T1 mapping, T2 mapping and MR elastography of the liver for detection and staging of liver fibrosis. Abdom Radiol 45:692–700. https://doi.org/10.1007/s00261-019-02382-9
Li Z, Sun J, Hu X, Huang N, Han G, Chen L, Zhou Y, Bai W, Yang X (2016) Assessment of liver fibrosis by variable flip angle T1 mapping at 3.0T. J Magn Reson Imaging 43:698–703. https://doi.org/10.1002/jmri.25030
Katsube T, Okada M, Kumano S, Hori M, Imaoka I, Ishii K, Kudo M, Kitagaki H, Murakami T (2011) Estimation of liver function using T1 mapping on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Invest Radiol 46:277–283. https://doi.org/10.1097/RLI.0b013e318200f67d
Breit HC, Block KT, Winkel DJ, Gehweiler JE, Henkel MJ, Weikert T, Stieltjes B, Boll DT, Heye TJ (2021) Heye, Evaluation of liver fibrosis and cirrhosis on the basis of quantitative T1 mapping: are acute inflammation, age and liver volume confounding factors? Eur J Radiol. https://doi.org/10.1016/j.ejrad.2021.109789
Kim JW, Lee YS, Park YS, Kim BH, Lee SY, Yeon JE, Lee CH (2020) Multiparametric MR Index for the diagnosis of non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease. Sci Rep. https://doi.org/10.1038/s41598-020-59601-3
Article PubMed PubMed Central Google Scholar
von Ulmenstein S, Bogdanovic S, Honcharova-Biletska H, Blümel S, Deibel AR, Segna D, Jüngst C, Weber A, Kuntzen T, Gubler C, Reiner CS (2022) Assessment of hepatic fibrosis and inflammation with look-locker T1 mapping and magnetic resonance elastography with histopathology as reference standard. Abdom Radiol 47:3746–3757
Torres US, D’ippolito G (2021) Multiparametric magnetic resonance imaging of the liver: bridging the gap between theory and practice—a bridge too far? Radiol Bras 54:5–6. https://doi.org/10.1590/0100-3984.2021.54.5e1
Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL, Bittencourt PL, Porta G, Boberg KM, Hofer H, Bianchi FB, Shibata M, Schramm C, Eisenmann de Torres B, Galle PR, McFarlane I, Dienes H-P, Lohse AW (2008) Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 48:169–176. https://doi.org/10.1002/hep.22322
Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD (2009) Liver biopsy. Hepatology 49:1017–1044. https://doi.org/10.1002/hep.22742
Group TFMCS, Bedossa P (1994) Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C, Hepatology 20 15–20 https://doi.org/10.1002/hep.1840200104
Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, Denk H, Desmet V, Korb G, MacSween RNM, Phillips MJ, Portmann BG, Poulsen H, Scheuer PJ, Schmid M, Thaler H (1995) Histological grading and staging of chronic hepatitis. J Hepatol 22:696–699. https://doi.org/10.1016/0168-8278(95)80226-6
Article CAS PubMed Google Scholar
Desmet VJ, Gerber M, Hoofnagle JH, Manns M, SCHEUER JH (1994) Scheuer, classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19:1513–1520. https://doi.org/10.1002/hep.1840190629
Article CAS PubMed Google Scholar
Harrison L, Gleeson D (2019) Stopping immunosuppressive treatment in autoimmune hepatitis (AIH): is it justified (and in whom and when)? Liver Int 39:610–620. https://doi.org/10.1111/liv.14051
Hernando D, Zhao R, Yuan Q, Aliyari Ghasabeh M, Ruschke S, Miao X, Karampinos DC, Mao L, Harris DT, Mattison RJ, Jeng MR, Pedrosa I, Kamel IR, Vasanawala S, Yokoo T, Reeder SB (2022) Reeder, multicenter reproducibility of liver iron quantification with 1.5-T and 3.0-T MRI. Radiology 306:e213256. https://doi.org/10.1148/radiol.213256
Yoon JH, Lee JM, Paek M, Han JK, Choi BI (2016) Quantitative assessment of hepatic function: modified look-locker inversion recovery (MOLLI) sequence for T1 mapping on Gd-EOB-DTPA-enhanced liver MR imaging. Eur Radiol 26:1775–1782. https://doi.org/10.1007/s00330-015-3994-7
Banerjee R, Pavlides M, Tunnicliffe EM, Piechnik SK, Sarania N, Philips R, Collier JD, Booth JC, Schneider JE, Wang LM, Delaney DW, Fleming KA, Robson MD, Barnes E, Neubauer S (2014) Multiparametric magnetic resonance for the non-invasive diagnosis of liver disease. J Hepatol 60:69–77. https://doi.org/10.1016/j.jhep.2013.09.002
留言 (0)